Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine cancer
    • Vaginal cancer
    • Vulval cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal cancer care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Jeannie Ferris Award
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events

Brain cancer

brain-mm cancer-types/brain-cancer/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Statistics
Loading...

Brain cancer in Australia statistics

  • Printer-friendly version
  • A|A

The following material has been sourced from the Australian Institute of Health and Welfare

Brain cancer incorporates ICD-10 cancer code C71 (Malignant neoplasm of brain)


Estimated number of new cases of brain cancer diagnosed in 2021

1,896 = male icon 1,171 males + female icon 725 females


Estimated % of all new cancer cases diagnosed in 2021

1.3%


Estimated number of deaths from brain cancer in 2021

1,528 = male icon 935 males + female icon 593 females


Estimated % of all deaths from cancer in 2021

3.1%


Chance of surviving at least 5 years (2013–2017)

22%


People living with brain cancer at the end of 2016 (diagnosed in the 5 year period 2012 to 2016)

3,322


New cases

In 2017, there were 1,809 new cases of brain cancer diagnosed in Australia (1,102 males and 707 females). In 2021, it is estimated that 1,896 new cases of brain cancer will be diagnosed in Australia (1,171 males and 725 females). In 2021, it is estimated that a person has a 1 in 161 (or 0.62%) risk of being diagnosed with brain cancer by the age of 85 (1 in 130 or 0.77% for males and 1 in 211 or 0.47% for females).

Figure 1. Estimated cancer incidence in Australia, 2021

Notes

  • Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
  • More information about incidence rates for the most common cancers diagnosed can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence)

In 2017, the age-standardised incidence rate was 6.7 cases per 100,000 persons (8.4 for males and 5.0 for females). In 2021, it is estimated that the age-standardised incidence rate will be 6.5 cases per 100,000 persons (8.2 for males and 4.8 for females). The incidence rate for brain cancer is expected to increase with age, peaking at age group 80–84 years.

Figure 2. Age-standardised incidence rates for brain cancer, 1982 to 2017, by sex

Notes

  • Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
    More information about incidence rates for brain cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence)

The number of new cases of brain cancer diagnosed increased from 854 (491 males and 363 females) in 1982 to 1,809 in 2017. Over the same period, the age-standardised incidence rate increased from 6.3 cases per 100,000 persons (7.5 for males and 5.1 for females) in 1982 to 6.7 cases per 100,000 in 2017.

Deaths

In 2019, there were 1,470 deaths from brain cancer in Australia (889 males and 581 females). In 2021, it is estimated that there will be 1,528 deaths (935 males and 593 females). In 2021, it is estimated that a person has a 1 in 191 (or 0.52%) risk of dying from brain cancer by the age of 85 (1 in 155 or 0.65% for males and 1 in 249 or 0.40% for females).

Figure 3. Estimated cancer mortality in Australia, 2021

Notes

  • Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
  • More information about mortality rates for the most common causes of cancer death can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality)

In 2019, the age-standardised mortality rate was 5.0 deaths per 100,000 persons (6.4 for males and 3.8 for females). In 2021, it is estimated that the age-standardised mortality rate will be 5.0 deaths per 100,000 persons (6.4 for males and 3.7 for females). The mortality rate for brain cancer is expected to increase with age, peaking at age group 80-84 years.

Mortality rates for brain cancer

Figure 4. Age-standardised mortality rates for brain cancer, 1982 to 2019, by sex

Notes

  • Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
  • More information about mortality rates for brain cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality)

The number of deaths from brain cancer increased from 663 (376 males and 287 females) in 1982 to 1,470 in 2019. Over the same period, the age-standardised mortality rate remained at 5.0 deaths per 100,000 persons (6.0 for males and 4.2 for females) in 1982 and 2019. 

Survival

In 2013–2017, individuals diagnosed with brain cancer had a 22% chance (22% for males and 23% for females) of surviving for five years compared to their counterparts in the general Australian population. Between 1988–1992 and 2013–2017, five-year relative survival for brain cancer improved from 20% to 22%.

Figure 5. 5-year relative survival for brain cancer, 1988–1992 to 2013–2017, by sex

Notes

  • Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
  • More information about 5-year relative survival rates for brain cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Relative survival rate’ section (https://ncci.canceraustralia.gov.au/outcomes/relative-survival-rate/5-year-relative-survival)

Prevalence

At the end of 2016, there were 1,306 people living who had been diagnosed with brain cancer that year, 3,322 people living who had been diagnosed with brain cancer in the previous 5 years (from 2012 to 2016) and 7,945 people living who had been diagnosed with brain cancer in the previous 35 years (from 1982 to 2016).

For more information, see Brain cancer on the NCCI website

The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes.  The NCCI website allows users to see visual representations of data on each indicator through interactive charts.

  • Last Updated
  • Relevant Links
updated: 5 January 2022 - 4:38am
Cancer Council, Brain cancer
American Cancer Society, Brain and spinal cord tumors in adults
National Cancer Institute (US), Adult central nervous system tumors treatment (PDQ®), patient version
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2022 - Cancer Australia